BiotechTube

Attention Deficit Hyperactivity Disorder

6 competing products in clinical development for Attention Deficit Hyperactivity Disorder.

Pipeline by Phase

Phase 2/31
Phase 31
Approved4

All Products (6)

ProductCompanyStageStatusHype
AtomoxetineEli LillyApprovedTerminated
85
Atomoxetine HydrochlorideEli LillyApprovedCompleted
85
AtomoxetineEli LillyApprovedCompleted
85
Atomoxetine hydrochloride + PlaceboEli LillyApprovedCompleted
85
AtomoxetineEli LillyPhase 3Completed
77
Atomoxetine + PlaceboEli LillyPhase 2/3Completed
65